Australia markets open in 8 hours 19 minutes

Shenzhen YHLO Biotech Co., Ltd. (688575.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
23.98+0.03 (+0.13%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 13.63B
Enterprise value 13.65B
Trailing P/E 39.97
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.43
Price/book (mrq)5.19
Enterprise value/revenue 7.48
Enterprise value/EBITDA 42.56

Trading information

Stock price history

Beta (5Y monthly) 0.50
52-week change 336.87%
S&P500 52-week change 322.38%
52-week high 326.60
52-week low 315.31
50-day moving average 324.38
200-day moving average 321.38

Share statistics

Avg vol (3-month) 33.62M
Avg vol (10-day) 34.02M
Shares outstanding 5568.31M
Implied shares outstanding 6574.34M
Float 8309.58M
% held by insiders 158.02%
% held by institutions 118.23%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.45
Forward annual dividend yield 41.88%
Trailing annual dividend rate 30.27
Trailing annual dividend yield 31.14%
5-year average dividend yield 4N/A
Payout ratio 475.00%
Dividend date 3N/A
Ex-dividend date 416 June 2023
Last split factor 21.4:1
Last split date 302 June 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 18.63%
Operating margin (ttm)15.69%

Management effectiveness

Return on assets (ttm)2.97%
Return on equity (ttm)10.48%

Income statement

Revenue (ttm)1.82B
Revenue per share (ttm)3.28
Quarterly revenue growth (yoy)-34.60%
Gross profit (ttm)N/A
EBITDA 372.47M
Net income avi to common (ttm)339.81M
Diluted EPS (ttm)0.60
Quarterly earnings growth (yoy)-18.70%

Balance sheet

Total cash (mrq)653.29M
Total cash per share (mrq)1.15
Total debt (mrq)585.48M
Total debt/equity (mrq)22.61%
Current ratio (mrq)2.33
Book value per share (mrq)4.62

Cash flow statement

Operating cash flow (ttm)358.52M
Levered free cash flow (ttm)-520.33M